Cincera Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
Cincera Therapeutics General Information
Description
Developed drugs for inflammatory and fibrotic illnesses designed to cure metabolic diseases. The company's drug treats difficult-to-treat inflammatory and fibrotic conditions associated with obesity and is also applicable in many other disease areas, including cancer and liver problems, enabling doctors to cure patients effectively.
Contact Information
Website
www.cinceratx.comCorporate Office
- 31 Queen Street
- Melbourne, Victoria 3000
- Australia
Corporate Office
- 31 Queen Street
- Melbourne, Victoria 3000
- Australia
Cincera Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 08-Feb-2026 | Completed | Generating Revenue | |||
| 3. Grant | 03-Sep-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 19-Feb-2018 | $5.56M | $5.56M | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2018 | Completed | Generating Revenue |
Cincera Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference |
Cincera Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cincera Therapeutics Patents
Cincera Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2026908591-A0 | Methods of treatment | Pending | 14-Oct-2026 | ||
| AU-2019902614-A0 | Inhibitor compounds | Inactive | 24-Jul-2019 | ||
| AU-2020316243-A1 | Inhibitor compounds | Active | 24-Jul-2019 | ||
| AU-2020316243-B2 | Inhibitor compounds | Active | 24-Jul-2019 | ||
| EP-4003986-A1 | Inhibitor compounds | Pending | 24-Jul-2019 | C07D413/12 |
Cincera Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cincera Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Australian Government's Department of Health | Government | |||
| Monash University | University |
Cincera Therapeutics FAQs
-
When was Cincera Therapeutics founded?
Cincera Therapeutics was founded in 2018.
-
Where is Cincera Therapeutics headquartered?
Cincera Therapeutics is headquartered in Melbourne, Australia.
-
What is the size of Cincera Therapeutics?
Cincera Therapeutics has 3 total employees.
-
What industry is Cincera Therapeutics in?
Cincera Therapeutics’s primary industry is Drug Discovery.
-
Is Cincera Therapeutics a private or public company?
Cincera Therapeutics is a Private company.
-
What is Cincera Therapeutics’s current revenue?
The current revenue for Cincera Therapeutics is .
-
How much funding has Cincera Therapeutics raised over time?
Cincera Therapeutics has raised $5.56M.
-
Who are Cincera Therapeutics’s investors?
Australian Government's Department of Health and Monash University have invested in Cincera Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
